of HIV exposure, and it is decided to initiate PEP▌PEP initiation 1. Sign the informed consent form (Conform to the conditions of the subjects, accept and sign the informed consent, and follow up for a total of 12 weeks)
Review of Trends in Molecular Medicine by Zhou Rongbin/Huang Yi team: Inflammasome and HIV-1 infection and treatment
Time of Update: 2022-06-08
This paper comprehensively and systematically summarizes the role and mechanism of the inflammasome and its mediated pyroptosis in HIV-1 infection and treatment, and discusses the possibility of the inflammasome as a therapeutic target for HIV-1-related diseases .
Co-infection with HBV, can HIV blockade be performed?
Time of Update: 2022-06-02
signing the informed consent form: PEP medication regimen: Bikempinol tablets, 1 tablet/day, for 28 days; follow-up requirements: 2 weeks, 4 weeks, 8 weeks, and 24 weeks after taking the medicine, follow-up visits, and at the same time closely monitor
New approach to anti-HIV antibody therapy shows promise in phase I clinical trial
Time of Update: 2022-05-28
>In this clinical trial, an AAV vector designed by MGH researchers carried a genetic sequence known as a broadly neutralizing HIV-1 antibody, which blocks HIV's ability to bind to CD4, which is the key to HIV before it infects cells Targeted immune cell
Scientists discover anti-HIV-1 antibody treatment suppresses viral infection
Time of Update: 2022-05-21
rebound virus . The study found that post-hoc sensitivity analyses did not predict when the virus would rebound . In individuals whose
Nature sub-journal publishes functional map of HIV-T cell interaction
Time of Update: 2022-05-19
At the same time, this study also illustrates the use of CRISPR technology to directly study virus-host interactions in human T cells, which is a new field of research .
Nat Commun: Transient viral exposure drives humoral immune responses in HIV-1 post-treatment controllers
Time of Update: 2022-05-16
The results of the study were published in the journal Nature Communications on April 11, 2022, with the title "Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers" .
Counterfeit HIV drug ravages DOJ probe into Gilead, GSK, J&J-related drugs
Time of Update: 2022-04-27
from Gilead, GlaxoSmithKline and Johnson & Johnson, and strives to clear the circulation system of patients' health and treatment. Substandard drugs . > Biktarvy
eLife: Mixing between populations may contribute to HIV transmission
Time of Update: 2022-04-26
. >Magosi explained: "Our findings suggest that community-based HIV testing and treatment initiatives are powerful tools for reducing HIV transmission, but targeted research support
The team of Professor Gao Feng and Professor Xianghui Yu isolated anti-HIV-1 broad-spectrum
Time of Update: 2022-04-26
The research team of Professor Gao Feng and Professor Yu Xianghui from the School of Life Sciences of Jilin University took the rhesus monkey animal model with the longest reported infection
A new study reveals why HIV persists in human tissues even after antiretroviral therapy
Time of Update: 2022-04-25
Elahi and his team found that in AIDS patients, killer T cells -- a type of white blood cell responsible for recognizing and destroying virus-infected cells -- were almost devoid of a protein called CD73 .
Cell Discovery: Dynamic changes of T cells in chronic HIV-infected patients and the impact of ART therapy
Time of Update: 2022-04-24
>+ T cells in the body will gradually decrease, the function of the immune system will be partially or completely lost, and eventually it will develop into AIDS (AIDS, or Acquired Immune Deficiency
New discoveries about the HIV life cycle
Time of Update: 2022-04-24
Their method, named FARS-seq (Functional Analysis of RNA Structure), helped identify regions of the HIV-1 genome that are important for dimerization and viral packaging .
Unraveling the immune complexities of SARS-CoV-2, HIV and pneumonia
Time of Update: 2022-04-23
At 10x Genomics' Global Symposium on Infectious Diseases, several leading scientists shared their latest findings, providing insight into how they are using innovative single-cell technologies to advance our understanding of the immune response after infection .
New study: Gene that makes new crown symptoms worse, can prevent HIV infection
Time of Update: 2022-04-19
A study led by Germany's Max Planck Institute for Evolutionary Anthropology (MPI-EVA) has shown that the same genetic variant that increases the risk of severe illness from COVID-19 protects against another serious disease -- which infects a person with HIV.
FDA approves GSK's long-acting HIV drug Cabenuva for teens
Time of Update: 2022-04-19
Reference source: ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
NEJM: A single high-dose liposomal regimen of amphotericin B for HIV-associated cryptococcal meningitis
Time of Update: 2022-04-19
with cryptococcal meningitis to an improved regimen (Day 1: single high-dose amphotericin B, per kg Body weight 10 mg + flucytosine for 14 days, 100 mg per day + fluconazole, 1200 mg per day) or WHO recommended regimen (amphotericin B deoxycholic acid, 1 mg
PLOS MED: Using rapid dual self-testing for syphilis and HIV among Chinese men who have sex with men to expand acceptance of syphilis testing
Time of Update: 2022-04-19
>. >references:>Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm
JAHA: Association of HIV serostatus and inflammation with aortic size
Time of Update: 2022-04-19
Vascular infection strokeIn a study published today in JAHA, the leading journal in the field of cardiovascular disease, researchers aimed to assess the association between aortic root and ascending aorta size, as measured by two-dimensional transthoracic echocardiography, and HIV serostatus.
Science: The super mutation of HIV virus doubles the speed of the AIDS process
Time of Update: 2022-04-18
>As we all know, HIV ( HIV ) is a retrovirus that can attack the human
